Antibody drug conjugates

This biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer.

HBM gets health boost from drug licensing deals

The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer Key Takeaways: Nona Biosciences, a subsidiary of…
2142.HK

Recent Articles

RELATED ARTICLES

  1. Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs.
    Akeso marks profit milestone with swift rights issue
    9926.HK
  2. InSilico seeks IPO boost to get AI drugs over the line
  3. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  4. Everest reaches new heights on growing drug sales
    1952.HK
  5. Sichuan Biokin chases Hong Kong listing after BSM drug deal
  6. Clinical trials come up short again for Alphamab Oncology
    9966.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva